M. Fromm

S-HAM Salvage Therapy of Relapsed and Refractory AML Followed by Interleukin 2 Postremission Therapy

W. Hiddemann, S. Lange, A. Heinecke, 1996 .

Late effects after treatment of twenty children with soft tissue sarcomas of the head and neck. Experience at a single institution with a review of the literature

S. Handler, P. Littman, R. B. Raney, 1986, Cancer.

Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial.

R. Abrams, C. Willett, A. Benson, 2008, JAMA.

Phase II randomized trial of two nonoperative regimens of induction chemotherapy followed by chemoradiation in patients with localized carcinoma of the esophagus: RTOG 0113.

J. Ajani, J. Bradley, R. Komaki, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Efficacy and patterns of failure for locally advanced cancer of the cervix treated with celebrex (celecoxib) and chemoradiotherapy in RTOG 0128.

Adam P Dicker, William Small, Patricia J Eifel, 2007, International journal of radiation oncology, biology, physics.

Glycogen Synthase Kinase 3 Beta Predicts Survival in Resected Adenocarcinoma of the Pancreas

R. Abrams, K. Griffith, Dafydd G. Thomas, 2015, Clinical Cancer Research.

A Phase II study of acute toxicity for Celebrex (celecoxib) and chemoradiation in patients with locally advanced cervical cancer: primary endpoint analysis of RTOG 0128.

A. Dicker, D. Gaffney, J. Ryu, 2005, International journal of radiation oncology, biology, physics.

Pure embryonal rhabdomyosarcoma of the fallopian tube.

E. Jenison, W. R. Hart, M. Fromm, 1997, Gynecologic oncology.

Cervix A PHASE II STUDY OF ACUTE TOXICITY FOR CELEBREX TM ( CELECOXIB ) AND CHEMORADIATION IN PATIENTS WITH LOCALLY ADVANCED CERVICAL CANCER : PRIMARY ENDPOINT ANALYSIS OF RTOG 0128

A. Dicker, P. Eifel, V. Avizonis, 2006 .